Keudell Biogen Inc. Transaction History

Keudell

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $168,611 - $216,690	-753 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$259.0 - $414.71 $195,027 - $312,276	753 New	753 $261,000
Q1 2021 Apr 13, 2021	SELL	$242.95 - $284.63 $231,531 - $271,252	-953 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$264.77 - $305.71 $5,560 - $6,419	-21 Reduced 2.16%	953 $270,000
Q2 2020 Jul 14, 2020	SELL	$258.66 - $342.55 $21,468 - $28,431	-83 Reduced 7.85%	974 $261,000
Q1 2020 Apr 20, 2020	SELL	$268.85 - $341.04 $61,835 - $78,439	-230 Reduced 17.87%	1,057 $334,000
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $11,883 - $16,419	-54 Reduced 4.03%	1,287 $382,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $5,436 - $6,097	25 Added 1.9%	1,341 $312,000
Q2 2019 Aug 23, 2019	BUY	$219.29 - $241.72 $288,585 - $318,103	1,316 New	1,316 $313,000
Q2 2019 Aug 21, 2019	SELL	$219.29 - $241.72 $417,528 - $460,234	-1,904 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$216.71 - $338.96 $412,615 - $645,379	1,904 New	1,904 $450,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

Stay updated on Keudell with notifications on news.